Monday, May 28, 2007
Replidyne (Daiichi Suntory / Asubio)
Faropenem® is the first oral penem antibiotic to reach an advanced stage of clinical development in the U.S. and is under development for community-acquired respiratory infections. Community antibiotics are generally used to treat infections acquired outside the hospital. Currently in Phase III trials.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment